Cargando…
Rosuvastatin Treatment for Preventing Contrast-Induced Acute Kidney Injury After Cardiac Catheterization: A Meta-Analysis of Randomized Controlled Trials
We performed a meta-analysis of randomized controlled trials (RCTs) to evaluate the protective effects of rosuvastatin on contrast-induced acute kidney injury (CI-AKI) and major adverse cardiovascular events (MACEs) in patients undergoing cardiac catherization. PubMed, MEDLINE, Web of Science, EMBAS...
Autores principales: | Yang, You, Wu, Yan-xian, Hu, Yun-zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554112/ https://www.ncbi.nlm.nih.gov/pubmed/26222855 http://dx.doi.org/10.1097/MD.0000000000001226 |
Ejemplares similares
-
Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials
por: Liang, Min, et al.
Publicado: (2017) -
Aldosterone and renin in cardiac patients referred for catheterization
por: Erne, Paul, et al.
Publicado: (2017) -
Remote Ischemic Preconditioning for Prevention of Acute Kidney Injury in Patients Undergoing On-Pump Cardiac Surgery: A Systematic Review and Meta-Analysis
por: Zhang, Yabing, et al.
Publicado: (2016) -
Meta-analysis of rosuvastatin efficacy in prevention of contrast-induced acute kidney injury
por: Zhang, Jing, et al.
Publicado: (2018) -
Comparing common doses (double-dose vs usual-dose) of atorvastatin for preventing contrast-induced acute kidney injury and mortality after coronary angiography
por: Bei, Wei-Jie, et al.
Publicado: (2017)